Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3.05% is 58% above its 5-year average of -7.34%, near the high end of its 5-year range (-34.08%–6.12%).
26.91% above its 12-month average of -4.17%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.86%.
OPERATING MARGIN
-3.05%
OPERATING MARGIN AVG TTM
-4.17%
OPERATING MARGIN AVG 3Y
-10.18%
OPERATING MARGIN AVG 5Y
-7.34%
OPERATING MARGIN AVG 10Y
-2.59%
OPERATING MARGIN AVG 15Y
0.57%
OPERATING MARGIN AVG 20Y
2.71%
CURRENT VS TTM AVG
+26.91%
CURRENT VS 3Y AVG
+70.05%
CURRENT VS 5Y AVG
+58.44%
CURRENT VS 10Y AVG
-17.54%
CURRENT VS 15Y AVG
-633.13%
CURRENT VS 20Y AVG
-212.74%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Orthofix Medical Inc.
Market Cap
$380.37M
Operating Margin
-3.05%
TTM Avg
-4.17%
3Y Avg
-10.18%
5Y Avg
-7.34%
Market Cap
$376.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$376.01M
Operating Margin
-31.98%
TTM Avg
-34.62%
3Y Avg
-233.89%
5Y Avg
-229.53%
Market Cap
$385.15M
Operating Margin
-94.08%
TTM Avg
-187.30%
3Y Avg
-226.23%
5Y Avg
-158.01%
Market Cap
$374.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-104.57%
5Y Avg
-176.82%
Market Cap
$369.50M
Operating Margin
-111.51%
TTM Avg
-90.32%
3Y Avg
-56.08%
5Y Avg
-435.91%
Market Cap
$396.31M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$397.99M
Operating Margin
-61.09%
TTM Avg
-74.66%
3Y Avg
-94.75%
5Y Avg
-94.75%
Market Cap
$361.64M
Operating Margin
-271.90%
TTM Avg
-418.31%
3Y Avg
-211.58%
5Y Avg
-783.53%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $380.37M | -3.05% | -4.17% | -10.18% | -7.34% |
| Zura Bio Limited (ZURA)vs › | $376.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Canopy Growth Corporation (CGC)vs › | $376.01M | -31.98% | -34.62% | -233.89% | -229.53% |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | -94.08% | -187.30% | -226.23% | -158.01% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | 0.00% | 0.00% | -104.57% | -176.82% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | -111.51% | -90.32% | -56.08% | -435.91% |
| Shoulder Innovations, Inc. (SI)vs › | $396.31M | -58.53% | -50.96% | -52.76% | -52.76% |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -61.09% | -74.66% | -94.75% | -94.75% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -271.90% | -418.31% | -211.58% | -783.53% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -14.22% | -4.51% | -387.94% | -2012.06% |
Gross Margin
69.6%
Operating Margin
-3.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3.86% |
| 2026-03-31 | -6.96% |
| 2025-12-31 | 6.12% |
| 2025-09-30 | -8.29% |
| 2025-06-30 | -7.88% |
| 2025-03-31 | -25.24% |
| 2024-12-31 | -5.32% |
| 2024-09-30 | -9.61% |
| 2024-06-30 | -12.54% |
| 2024-03-31 | -15.55% |
| 2023-12-31 | -9.14% |
| 2023-09-30 | -13.29% |
| 2023-06-30 | -19.59% |
| 2023-03-31 | -34.08% |
| 2022-12-31 | -9.04% |
| 2022-09-30 | -5.08% |
| 2022-06-30 | 5.62% |
| 2022-03-31 | -2.89% |
| 2021-12-31 | -7.48% |
| 2021-09-30 | -0.28% |
| 2021-06-30 | 3.52% |
| 2021-03-31 | -2.76% |
| 2020-12-31 | 3.15% |
| 2020-09-30 | 3.76% |
| 2020-06-30 | -28.71% |
| 2020-03-31 | 6.54% |
| 2019-12-31 | 3.37% |
| 2019-09-30 | -16.64% |
| 2019-06-30 | 0.39% |
| 2019-03-31 | -4.08% |
| 2018-12-31 | 10.24% |
| 2018-09-30 | 3.50% |
| 2018-06-30 | 6.30% |
| 2018-03-31 | 7.24% |
| 2017-12-31 | 15.28% |
| 2017-09-30 | 8.58% |
| 2017-06-30 | 7.34% |
| 2017-03-31 | 5.76% |
| 2016-12-31 | 6.83% |
| 2016-09-30 | 9.41% |
| 2016-06-30 | -2.53% |
| 2016-03-31 | 7.22% |
| 2015-12-31 | 7.05% |
| 2015-09-30 | 4.09% |
| 2015-06-30 | 4.88% |
| 2015-03-31 | -8.01% |
| 2014-12-31 | 3.94% |
| 2014-09-30 | 6.44% |
| 2014-06-30 | 6.64% |
| 2014-03-31 | 2.43% |
| 2013-12-31 | -6.01% |
| 2013-09-30 | -16.82% |
| 2013-06-30 | 8.96% |
| 2013-03-31 | 4.01% |
| 2012-12-31 | 21.85% |
| 2012-09-30 | 18.76% |
| 2012-06-30 | 17.21% |
| 2012-03-31 | 15.40% |
| 2011-12-31 | 11.22% |
| 2011-09-30 | 15.90% |
| 2011-06-30 | 12.94% |
| 2011-03-31 | -18.73% |
| 2010-12-31 | 11.71% |
| 2010-09-30 | 13.67% |
| 2010-06-30 | 14.85% |
| 2010-03-31 | 23.01% |
| 2009-12-31 | 15.26% |
| 2009-09-30 | 13.14% |
| 2009-06-30 | 9.92% |
| 2009-03-31 | 8.14% |
| 2008-12-31 | 7.14% |
| 2008-09-30 | -223.91% |
| 2008-06-30 | 8.87% |
| 2008-03-31 | 9.05% |
| 2007-12-31 | -6.44% |
| 2007-09-30 | 13.04% |
| 2007-06-30 | 12.66% |
| 2007-03-31 | 12.77% |
| 2006-12-31 | 10.83% |
| 2006-09-30 | -36.53% |
| 2006-06-30 | 17.79% |
| 2006-03-31 | 14.37% |
| 2005-12-31 | 16.46% |
| 2005-09-30 | 18.22% |
| 2005-06-30 | 20.83% |
| 2005-03-31 | 20.09% |
| 2004-12-31 | 19.58% |
| 2004-09-30 | 20.42% |
| 2004-06-30 | 18.65% |
| 2004-03-31 | 18.08% |
| 2003-12-31 | 22.00% |
| 2003-09-30 | 17.22% |
| 2003-06-30 | 20.21% |
| 2003-03-31 | 20.22% |
| 2002-12-31 | 23.89% |
| 2002-09-30 | 23.58% |
